In this study, we aimed to investigate the potential importance of PDIA3 in glioblastoma, one of the most aggressive forms of brain tumor, by examining the antiproliferative effects of PDIA3 inhibition in two glioblastoma cell line models (T98G and U-87 MG, TMZ-resistant and -sensitive, respectively). Here, PDIA3 is linked to brain neoplasm.